China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)

Market Cap	19.58B
Revenue (ttm)	11.02B
Net Income (ttm)	1.56B
Shares Out	1.03B
EPS (ttm)	1.51
PE Ratio	12.60
Forward PE	11.18
Dividend	0.47 (2.47%)
Ex-Dividend Date	Jul 11, 2025

Volume	4,159,600
Average Volume	14,829,672
Open	19.06
Previous Close	19.06
Day's Range	18.99 - 19.10
52-Week Range	17.34 - 26.15
Beta	0.03
RSI	37.44
Earnings Date	Aug 23, 2025

About SHA:600062

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure, blood sugar, injection, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, and other. The company was founded in 1939 and is headquartered in Beijing, the People’s Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing Pharmaceutical Group Co., Ltd.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1939
• Employees: 13,414
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600062

Financial Performance

In 2024, SHA:600062's revenue was 11.21 billion, a decrease of -0.87% compared to the previous year's 11.31 billion. Earnings were 1.63 billion, a decrease of -2.55%.